Surgery Doctors in Lancaster, OH Accepting Medicare

8 Surgery doctors found. Showing 1 - 8

Timothy John Custer, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2405 N Columbus St, Suite 250, Lancaster, OH 43130 Phone: 740-654-6213    Fax: 740-654-3346

Dr. James Pan, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 618 Pleasantville Rd, Suite 302, Lancaster, OH 43130 Phone: 740-687-6910    Fax: 740-689-9546

Dr. Scott Owen Johnson, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2405 N Columbus St, Ste 250, Lancaster, OH 43130 Phone: 740-654-6213    Fax: 740-654-3346

Jeffrey Keith Yenchar, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 618 Pleasantville Rd Ste 301, Lancaster, OH 43130 Phone: 740-687-5437    Fax: 740-687-6330

David Michael Hasl, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2405 N Columbus St, Ste 250, Lancaster, OH 43130 Phone: 740-654-6213    Fax: 740-654-3346

David J Robertson, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 618 Pleasantville Rd Ste 301, Lancaster, OH 43130 Phone: 740-687-5437    Fax: 740-687-6330

Dr. Jason Lionel Andre, M.D. Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 618 Pleasantville Rd Ste 302, Lancaster, OH 43130 Phone: 740-687-6910    Fax: 740-689-9546

Margaret Sterrett Sawyer, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 618 Pleasantville Rd Ste 301, Lancaster, OH 43130 Phone: 740-687-5437    Fax: 740-687-6330

News Archive

Coronado completes series of private financings

Coronado Biosciences, Inc., a privately held company engaged in innovative oncology drug development, announced completion of a series of private financings in 2010, resulting in aggregate gross proceeds to the Company of approximately $21.6 million.

Bayer HealthCare and German Cancer Research Center to extend strategic alliance in search of novel cancer therapeutics

Bayer HealthCare (Bayer) and the German Cancer Research Center (DKFZ) will extend their successful strategic research alliance in search of novel cancer therapeutics by focusing their activities also on the field of immunotherapy. Immunotherapies are a promising approach to treat cancer with the aim to selectively reactivate the body's own immune system so that it attacks tumor cells.

Covance enters into accelerated share repurchase transaction with JPMorgan

Covance Inc. announced today it entered into an accelerated share repurchase transaction with JPMorgan Chase Bank. Covance will repurchase shares of its common stock pursuant to the ASR Agreement as part of the $250 million share repurchase program that it announced on September 28, 2010.

NIH-funded research consortium aims to advance treatments for frontotemporal lobar degeneration

The National Institutes of Health has awarded a five-year, multi-investigator research grant expected to total more than $63 million to Mayo Clinic and the University of California, San Francisco, to advance treatments for frontotemporal lobar degeneration

AARDA releases white paper to educate its members, patient community about biosimilar medicines

The American Autoimmune Related Diseases Association, a national nonprofit health organization dedicated to increasing awareness of autoimmune diseases, today issued a white paper to educate its membership and the patient community about biosimilar medicines after a survey found most patients were generally unaware of this new category of medicines which may soon be approved in the U.S.

Read more Medical News

› Verified 6 days ago